An alternative to Paxlovid, the only antiviral pills approved by the US Food and Drug Administration to treat COVID-19, is on ...

Researchers have found in a new study that among COVID-19 patients with asthma, those who received Paxlovid had a ...

A new study suggests Paxlovid may not reduce the risk of covid-19 hospitalizations and all-cause deaths in vaccinated adults ...

The first to launch was the ACTT-1 trial, though it didn't have that name when it began at the University of Nebraska Medical ...

The lack of available medications in the United States for COVID post-exposure prophylaxis leaves household members in close contact with someone who is infected vulnerable to developing COVID ...

What's more, Paxlovid may still be helpful for certain high-risk groups, Mafi said. Paxlovid, a combination of nirmatrelvir ...

In the large clinical trials that proved the benefits of statins, about a quarter of people complained of myalgia, although ...

Among asthma patients infected with COVID-19, those who received the antiviral drug nirmatrelvir-ritonavir (Paxlovid) had ...

The Federal Executive Council on Wednesday approved 13 contracts for the Ministry of Works, aimed at rehabilitating, ...

Orbis Medicines, a leader in oral macrocycle drug discovery, today announces the appointment of Mikael Dolsten, M.D., Ph.D., former Chief Scientific O ...

targeting the Mpro (3CL protease), without the need for co-administration of ritonavir. Forward-Looking Statements Some of ...